BMO Capital analyst Michael Markidis lowered the firm’s price target on NorthWest Healthcare (NWHUF) to C$5.25 from C$5.50 and keeps a Market Perform rating on the shares.
Education
About Us
Working with TipRanks
Follow Us
1
BMO Capital analyst Michael Markidis lowered the firm’s price target on NorthWest Healthcare (NWHUF) to C$5.25 from C$5.50 and keeps a Market Perform rating on the shares.